Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#GMP Cell Therapy Consumables Market CAGR Outlook And Future Development#_x000D_
The gmp cell therapy consumables market has experienced substantial expansion in recent years. It is anticipated to increase from $22.73 billion in 2025 to $28.79 billion in 2026, registering a compound annual growth rate (CAGR) of 26.7%. This historic growth can be linked to several factors, including the rising number of clinical cell therapy trials, the advancement of regenerative medicine research, the wider adoption of gmp manufacturing standards, increased financial commitments to cell-based therapies, and the availability of advanced cell culture tools._x000D_
_x000D_
The gmp cell therapy consumables market size is anticipated to experience substantial growth over the next few years. It is projected to expand to $73.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 26.6%. This expansion during the forecast period can be attributed to the increasing commercialization of cell therapies, a rising need for scalable GMP production, the expansion of gene and immunotherapy pipelines, a growing emphasis on process automation, and increased regulatory oversight in cell therapy manufacturing. Significant trends expected in the forecast period include an escalating demand for GMP-compliant cell therapy consumables, the rising adoption of single-use bioprocessing products, the growing use of automated cell processing systems, the expansion of standardized cell culture solutions, and an enhanced focus on quality and regulatory compliance._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#GMP Cell Therapy Consumables Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The expanding occurrence of chronic diseases is anticipated to propel the growth of the GMP cell therapy consumables market in the coming years. A chronic disease is defined as an ailment persisting for three months or longer, which may deteriorate over time. The increase in chronic illnesses prompts greater research and development efforts into innovative cell therapies designed to address these long-term conditions. Demand for GMP consumables is rising as cell therapy applications extend across various chronic diseases, making quality assurance in clinical trials essential. Robust regulatory compliance and patient demand for cutting-edge therapies further contribute to the market’s expansion. For instance, in June 2024, data from the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, representing an 18% increase from 3,065,825 cases in 2022. Thus, the escalating prevalence of chronic diseases is a primary driver for the growth of the GMP cell therapy consumables market._x000D_
_x000D_
#GMP Cell Therapy Consumables Market Segment Breakdown: Which Categories Lead On Revenue?#_x000D_
The gmp cell therapy consumables market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Kits, Reagents Or Molecular Biology Reagents, Growth Factors Or Cytokines And Interleukins, Other Products_x000D_
2) By Cell Therapy: NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy_x000D_
3) By Process: Cell Collection And Characterization Or Sorting And Separation, Cell Culture And Expansion Or Preparation, Cryopreservation, Cell Processing And Formulation, Cell Isolation And Activation_x000D_
4) By End-Use: Clinical, Commercial_x000D_
_x000D_
Subsegments:_x000D_
1) By Kits: Cell Culture Kits, Cell Isolation Kits, Transfection Kits _x000D_
2) By Reagents Or Molecular Biology Reagents: Buffers And Solutions, Enzymes, Staining Reagents_x000D_
3) By Growth Factors Or Cytokines And Interleukins: Hematopoietic Growth Factors, Immunomodulatory Cytokines _x000D_
4) By Other Products: Cell Culture Vessels, Media And Supplements_x000D_
_x000D_
#GMP Cell Therapy Consumables Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Leading firms within the GMP cell therapy consumables market are creating GMP-compliant CD34+ hematopoietic stem cells (HSCs) to aid advanced therapeutic applications. These GMP-compliant CD34+ hematopoietic stem cells (HSCs) are defined as a particular kind of stem cell featuring the CD34 marker on their surface, manufactured in accordance with Good Manufacturing Practice (GMP) standards. As an illustration, in April 2024, OrganaBio, a pharmaceutical company based in the US, introduced HematoPAC-HSC-CB-GMP, offering an on-demand supply of GMP-compliant CD34+ hematopoietic stem cells (HSCs) sourced from fresh human cord blood. OrganaBio leverages its considerable expertise in cell isolation and GMP manufacturing processes to achieve high yields of extremely viable CD34+ HSCs within 24 hours of collection. This introduction intends to accelerate the creation of future therapies, encompassing treatments for blood cancers and various genetic disorders._x000D_
_x000D_
#GMP Cell Therapy Consumables Market Top Companies Driving Competitive Growth#_x000D_
Major companies operating in the gmp cell therapy consumables market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, Sartorius AG, Corning Incorporated, Avantor Inc., Fresenius Kabi AG, Miltenyi Biotec, Bio-Techne Corp, STEMCELL Technologies Inc., FUJIFILM Irvine Scientific Inc., BioLife Solutions Inc., PromoCell GmbH, PeproTech Inc., Sino Biological Inc., Wilson Wolf Corporation, Cellexus Ltd., MaxCyte Inc., BioLegend Inc., Repligen Corporation, Terumo Corporation _x000D_
_x000D_
#View The Full GMP Cell Therapy Consumables Market Report:#_x000D_
_x000D_
#GMP Cell Therapy Consumables Market Global Footprint: Which Region Leads The Industry?#_x000D_
North America was the largest region in the GMP cell therapy consumables market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gmp cell therapy consumables market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.